Dietary iron overload disease

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:139507OMIM:601195E83.1
Who is this for?
Show terms as
30Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Dietary iron overload disease, also known as African iron overload or Bantu siderosis, is a condition characterized by excessive accumulation of iron in the body resulting primarily from the consumption of large quantities of iron-rich traditional home-brewed beverages, particularly those fermented in iron pots or drums. This condition has been predominantly described in sub-Saharan African populations. While the primary driver is dietary iron excess, there is evidence suggesting that a genetic susceptibility factor (distinct from the HFE gene mutations responsible for hereditary hemochromatosis) may contribute to the development of iron overload in affected individuals, as not all people exposed to the same dietary iron load develop the disease. The excess iron accumulates in multiple organs, particularly the liver, spleen, bone marrow, and pancreas. Over time, iron deposition in the liver can lead to hepatic fibrosis and cirrhosis, portal hypertension, and an increased risk of hepatocellular carcinoma. Iron loading in other organs may result in diabetes mellitus, cardiomyopathy, and osteoporosis. Patients may present with hepatomegaly, abdominal pain, fatigue, and signs of liver dysfunction. Ascorbic acid (vitamin C) deficiency is also commonly observed due to oxidative degradation by excess iron. Treatment primarily involves reducing dietary iron intake by avoiding iron-rich traditional beverages and foods prepared in iron containers. Phlebotomy (therapeutic blood removal) may be employed to reduce body iron stores, similar to the approach used in hereditary hemochromatosis. Iron chelation therapy may be considered in cases where phlebotomy is not feasible. Management of complications such as liver disease, diabetes, and heart failure is also an important component of care. Early identification and dietary modification can help prevent progression to irreversible organ damage.

Also known as:

Clinical phenotype terms— hover any for plain English:

Hepatic periportal necrosisHP:0002614Viral hepatitisHP:0006562Elevated transferrin saturationHP:0012463Elevated hepatic iron concentrationHP:0012465Hepatocellular carcinomaHP:0001402Micronodular cirrhosisHP:0001413Increased circulating cortisol levelHP:0003118Abnormal adrenal morphologyHP:0011732Abnormal thyroid morphologyHP:0011772Abnormal pancreas morphologyHP:0012090Hepatic bridging fibrosisHP:0012852
Inheritance

Multifactorial

Caused by a mix of several genes and environmental factors

Age of Onset

Adult

Begins in adulthood (age 18 or older)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Dietary iron overload disease.

View clinical trials →

No actively recruiting trials found for Dietary iron overload disease at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Dietary iron overload disease community →

Specialists

Showing 25 of 30View all specialists →
CM
Caroline Moreau, MD
AUSTIN, TX
Specialist
PI on 1 active trial
DP
David DEVOS, MD, PhD
Specialist
PI on 1 active trial
JM
Jane Hankins, MD, MS
MEMPHIS, TN
Specialist
PI on 4 active trials
AM
Ariel Koren, MD
Specialist
PI on 10 active trials1 Dietary iron overload disease publication
JM
John Porter, MD
Specialist
PI on 2 active trials
DS
Daniela Mathov, Student
Specialist
PI on 1 active trial
MM
Mariane de montalembert, MD/PhD
Specialist
PI on 1 active trial
GM
Gary M. Brittenham, M.D.
Specialist
PI on 1 active trial
GM
Griffin P Rodgers, M.D.
BETHESDA, MD
Specialist
PI on 2 active trials
MP
Michael B Zimmermann, MD, PhD
CROMWELL, CT
Specialist
PI on 1 active trial
RD
Rajarshi Banerjee, BM BCh MS DPhil
Specialist
PI on 1 active trial
LP
Lise L Gluud, Professor
Specialist
PI on 1 active trial
SM
Sheinei Alan, MD
FALLS CHURCH, VA
Specialist
PI on 1 active trial
FM
Fabrice LAINE, MD
Specialist
PI on 1 active trial
DP
David Devos, MD, PhD
Specialist
PI on 1 active trial
MM
Mary Ann Knovich, MD
CHARLOTTE, NC
Specialist
PI on 1 active trial
JD
Jidong Jia, Doctor
Specialist
PI on 1 active trial
NP
Nicolai J Wewer Albrechtsen, MD, PhD
Specialist
PI on 1 active trial
DM
Denis Soulieres, MD
Specialist
PI on 1 active trial
MM
Maria E Lai, MD
SAINT CLAIR SHORES, MI
Specialist
PI on 1 active trial
JP
John C Wood, MD, PhD
Specialist
PI on 2 active trials
JM
John B Porter, MD
Specialist
PI on 1 active trial
PP
Pradyumna Phatak
ROCHESTER, NY
Specialist
PI on 1 active trial1 Dietary iron overload disease publication

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Dietary iron overload disease.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Dietary iron overload diseaseForum →

No community posts yet. Be the first to share your experience with Dietary iron overload disease.

Start the conversation →

Latest news about Dietary iron overload disease

No recent news articles for Dietary iron overload disease.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Dietary iron overload disease

What is Dietary iron overload disease?

Dietary iron overload disease, also known as African iron overload or Bantu siderosis, is a condition characterized by excessive accumulation of iron in the body resulting primarily from the consumption of large quantities of iron-rich traditional home-brewed beverages, particularly those fermented in iron pots or drums. This condition has been predominantly described in sub-Saharan African populations. While the primary driver is dietary iron excess, there is evidence suggesting that a genetic susceptibility factor (distinct from the HFE gene mutations responsible for hereditary hemochromatos

How is Dietary iron overload disease inherited?

Dietary iron overload disease follows a multifactorial inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Dietary iron overload disease typically begin?

Typical onset of Dietary iron overload disease is adult. Age of onset can vary across affected individuals.

Which specialists treat Dietary iron overload disease?

25 specialists and care centers treating Dietary iron overload disease are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.